-
-
-
-
-
-
-
BioCryst Reports First Quarter 2026 Financial Results and Provides Business Update
-
-
-
-
-
-
-
BioCryst Reports Full Year 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Astria Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
-
-
-
-
-
-
-
BofA lists 13 SMID cap stocks that could rebound
-
-
-
-
-
-
-
BioCryst (BCRX) names Babar Ghias as CFO and head of corporate development
-
-
-
-
-
-
-
Biotech sector Q1 earnings preview from RBC Capital Markets
-
-
-
-
-
-
-
BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update
-
1,206,985 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

